|
Market Closed -
Nasdaq
16:00:00 2026-10-07 EDT
|
5-day change | 1st Jan Change | ||
| 19.65 USD | -0.46% |
|
-2.48% | -26.43% |
| 09-28 | Neuren Says US Patent Allowance Could Extend Trofinetide Protection to 2041 | MT |
| 09-28 | Acadia Pharmaceuticals Gets US Patent Office Allowance for Trofinetide Dosing Patent | MT |
Transcripts
Search
No results match your criteria
Select your edition
All financial news and data tailored to specific country editions

















